Cargando…

A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?

The forced expiratory volume in one second (FEV1) is regularly used for the follow-up of patients with non-cystic fibrosis bronchiectasis (nCF-BE). The lung clearance index (LCI), measured by the multiple breath washout test, has been recently proposed as a lung function measure and a potential tool...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkoussa, Wael, Hanssens, Laurence, Sputael, Valerie, De Lucia, Frederico, Quentin, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217453/
https://www.ncbi.nlm.nih.gov/pubmed/37238339
http://dx.doi.org/10.3390/children10050791
_version_ 1785048541570269184
author Alkoussa, Wael
Hanssens, Laurence
Sputael, Valerie
De Lucia, Frederico
Quentin, Christine
author_facet Alkoussa, Wael
Hanssens, Laurence
Sputael, Valerie
De Lucia, Frederico
Quentin, Christine
author_sort Alkoussa, Wael
collection PubMed
description The forced expiratory volume in one second (FEV1) is regularly used for the follow-up of patients with non-cystic fibrosis bronchiectasis (nCF-BE). The lung clearance index (LCI), measured by the multiple breath washout test, has been recently proposed as a lung function measure and a potential tool more sensitive than the FEV1 measured by spirometry in assessing airway changes seen on imaging. While several data have been endorsed as a useful endpoint in clinical trials of patients with early or mild CF lung disease and as the main outcome measure in clinical trials with CFTR modulators in children and adolescents with CF, few data are available in the context of non-CF bronchiectasis. The aim of this pilot study was to compare the LCI with the FEV1 as well as the forced vital capacity (FVC), the forced expiratory flow at 25–75% of the FVC (FEF 25–75%), and chest imaging based on the modified Reiff score in patients with primary ciliary dyskinesia (PCD) and non-CF, non-PCD bronchiectasis (PCD-BE and nCFnPCD-BE). Additionally, we compared each test’s duration and the preferred technique. Twenty children were included; nine had PCD-BE and eleven had nCFnPCD-BE. The median age was twelve years (ages ranging between five and eighteen years). The median LCI was seven while the median z-scores of the FEV1, FVC, and FEF 25–75% were −0.6, 0, and −0.9, respectively. No significant associations or correlations were observed between LCI, spirometric parameters, or the modified Reiff score. However, nearly half of the population (n = 9) had an abnormal LCI, while only 10% had an abnormal FEV1. A total of 75% of children preferred MBW, despite it lasting five times longer than spirometry. In this paper, the authors suggest that LCI might be useful in a cohort of pediatric patients with PCD-BE and nCFnPCD-BE for detecting early lung function changes during their follow-up. Additionally, MBW seems to be preferred by patients. These data may encourage further studies on this topic.
format Online
Article
Text
id pubmed-10217453
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102174532023-05-27 A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis? Alkoussa, Wael Hanssens, Laurence Sputael, Valerie De Lucia, Frederico Quentin, Christine Children (Basel) Article The forced expiratory volume in one second (FEV1) is regularly used for the follow-up of patients with non-cystic fibrosis bronchiectasis (nCF-BE). The lung clearance index (LCI), measured by the multiple breath washout test, has been recently proposed as a lung function measure and a potential tool more sensitive than the FEV1 measured by spirometry in assessing airway changes seen on imaging. While several data have been endorsed as a useful endpoint in clinical trials of patients with early or mild CF lung disease and as the main outcome measure in clinical trials with CFTR modulators in children and adolescents with CF, few data are available in the context of non-CF bronchiectasis. The aim of this pilot study was to compare the LCI with the FEV1 as well as the forced vital capacity (FVC), the forced expiratory flow at 25–75% of the FVC (FEF 25–75%), and chest imaging based on the modified Reiff score in patients with primary ciliary dyskinesia (PCD) and non-CF, non-PCD bronchiectasis (PCD-BE and nCFnPCD-BE). Additionally, we compared each test’s duration and the preferred technique. Twenty children were included; nine had PCD-BE and eleven had nCFnPCD-BE. The median age was twelve years (ages ranging between five and eighteen years). The median LCI was seven while the median z-scores of the FEV1, FVC, and FEF 25–75% were −0.6, 0, and −0.9, respectively. No significant associations or correlations were observed between LCI, spirometric parameters, or the modified Reiff score. However, nearly half of the population (n = 9) had an abnormal LCI, while only 10% had an abnormal FEV1. A total of 75% of children preferred MBW, despite it lasting five times longer than spirometry. In this paper, the authors suggest that LCI might be useful in a cohort of pediatric patients with PCD-BE and nCFnPCD-BE for detecting early lung function changes during their follow-up. Additionally, MBW seems to be preferred by patients. These data may encourage further studies on this topic. MDPI 2023-04-27 /pmc/articles/PMC10217453/ /pubmed/37238339 http://dx.doi.org/10.3390/children10050791 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alkoussa, Wael
Hanssens, Laurence
Sputael, Valerie
De Lucia, Frederico
Quentin, Christine
A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?
title A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?
title_full A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?
title_fullStr A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?
title_full_unstemmed A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?
title_short A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?
title_sort pilot study of lung clearance index as a useful outcome marker in the follow-up of pediatric patients with non-cystic fibrosis bronchiectasis?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217453/
https://www.ncbi.nlm.nih.gov/pubmed/37238339
http://dx.doi.org/10.3390/children10050791
work_keys_str_mv AT alkoussawael apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT hanssenslaurence apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT sputaelvalerie apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT deluciafrederico apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT quentinchristine apilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT alkoussawael pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT hanssenslaurence pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT sputaelvalerie pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT deluciafrederico pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis
AT quentinchristine pilotstudyoflungclearanceindexasausefuloutcomemarkerinthefollowupofpediatricpatientswithnoncysticfibrosisbronchiectasis